The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known.
Abstract
PROLOGUE: Anyone who watches television or reads newspapers or magazines in modern-day America cannot help but notice the dramatic upsurge in the number of prescription drug ads. Drug companies spent $905 million on direct-to-consumer (DTC) advertising in the first half of 1999 alone—a 43 percent increase over spending levels a year earlier, according to IMS Health. CBS HealthWatch reports that in 1998, 66 percent of drug consumers in the central United States recalled seeing a particular product advertised in print, and 61 percent of Southern consumers recalled seeing one advertised on TV. The explosion in DTC drug advertising is fueling the trend toward better-informed consumers. Although this trend might appear benign, it is changing the physician/patient relationship. The authors of this study conclude that evidence is accumulating to suggest that clinical quality of care is harmed by DTC advertising. Michael Wilkes is an associate professor of medicine at the University of California, Los Angeles (UCLA), where he is senior chair of the School of Medicine's four-year Doctoring Curriculum. Robert Bell is a professor of communication at UC Davis. He holds a doctoral degree in communications from the University of Texas, Austin. Richard Kravitz is a professor in the Department of Internal Medicine at UC Davis and directs its Center for Health Services Research in Primary Care. He holds a medical degree from UC San Francisco. ABSTRACT: We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health Behavior and Health Education: Theory, Research, and Practice
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-350_1 · Cited by 13,207
From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
Kushner (2021) · doi:10.12788/jfp · Cited by 3,799
The Journal of Family Practice
(1997) · The American Journal of Family Therapy · doi:10.1080/01926189708251066 · Cited by 3,067
Current issues and research in advertising
Leigh, J. H., & Martin, C. R. (1978) · Medical Entomology and Zoology · Cited by 954
Chassin, M. R. (1987) · JAMA · doi:10.1001/jama.258.18.2533 · Cited by 655
Scientific versus commercial sources of influence on the prescribing behavior of physicians
Avorn, J., Chen, M., & Hartley, R. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90911-1 · Cited by 559
The Appropriateness of Carotid Endarterectomy
Winslow, C. M., Solomon, D. H., Chassin, M. R., Kosecoff, J., Merrick, N. J., & Brook, R. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181201 · Cited by 488
Direct-to-consumer prescription drug advertising and the public
Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.01049.x · Cited by 214
Self-citationDirect-to-Consumer Marketing of Prescription Drugs: Creating Consumer Demand
Hollon, M. F. (1999) · JAMA · doi:10.1001/jama.281.4.382 · Cited by 174
Cited by
The Shifting Engines of Medicalization
Conrad, P. (2005) · Journal of Health and Social Behavior · doi:10.1177/002214650504600102 · Cited by 1,074
The Increasing Predictive Validity of Self-Rated Health
Schnittker, J., & Bacak, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084933 · Cited by 902
Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005) · JAMA · doi:10.1001/jama.293.16.1995 · Cited by 586
Self-citationPromotion of Prescription Drugs to Consumers
Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012075 · Cited by 420
Americans' Views on the Use and Regulation of Dietary Supplements
Blendon, R. J., DesRoches, C. M., Benson, J. M., Brodie, M., & Altman, D. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.6.805 · Cited by 297
Metadata
- Authors
- Wilkes, M. S., Bell, R. A., & Kravitz, R. L.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2000-03
- Volume
- 19
- Issue
- 2
- Pages
- 110-128
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2095778652
- Cited by
- 387
- References
- 18
- FWCI
- 17.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known. https://app.cochat.ai/papers/10.1377/hlthaff.19.2.110
- The paper
- Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known. Health Affairs. https://doi.org/10.1377/hlthaff.19.2.110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.